two.7 Family Office has invested in Avelios, a developer of a modular AI-driven hospital information system aimed at transforming healthcare operations in Germany.
Target Information
Avelios, a pioneering technology firm, specializes in developing a modular, cloud-based, and AI-driven hospital information system. This innovative platform aims to digitalize and efficiently integrate clinical processes, thereby enhancing healthcare delivery and operational efficiency. By creating a comprehensive "Operating System" for the healthcare sector, Avelios positions itself as a key player in transforming how healthcare providers manage information and processes.
Industry Overview in Germany
The healthcare industry in Germany is one of the largest and most advanced systems in the world, characterized by a mix of public and private providers. With a strong emphasis on technology and innovation, Germany has seen significant investments in digital health solutions. The ongoing shift towards digitalization represents a critical opportunity for companies like Avelios, as the demand for integrated health information systems continues to grow.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Germany's healthcare system is undergoing substantial reforms aimed at improving efficiency, reducing costs, and enhancing patient care quality. The increasing adoption of digital tools and electronic health record
Similar Deals
China Development Industrial Bank → Anbogen Therapeutics
2024
M Ventures, Debiopharm Innovation Fund → Iktos
2023
zwei.7
invested in
Avelios
in 2025
in a Series A deal